| Serial Number | 97693879 |
| Word Mark | ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICES |
| Filing Date | Monday, November 28, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 18, 2024 |
| Registration Number | 7423244 |
| Registration Date | Tuesday, June 18, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 8, 2023 |
| Description of Mark | The mark consists of the word "ELAHERE" in block capital letters, stacked above "mirvetuximab soravtansine", "injection 100 mg", and "SUPPORT SERVICES", with the design of a half circle sunburst to the left of these words made up of trapezoid-shaped lines, each divided into three sections of different shades, arrayed around the upper left corner of the first "E" in "ELAHERE". |
| Pseudo Mark | ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION ONE ZERO ZERO MG SUPPORT SERVICES; ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION ONE HUNDRED MG SUPPORT SERVICES |
| Goods and Services | Providing health insurance information about health insurance benefits, medication insurance coverage, insurance reimbursement, insurance payer policies and patient financial assistance to patients; financial consultation to medical patients in identification of health insurance alternatives; providing patient assistance programs, namely, providing financial assistance programs to provide access to pharmaceutical preparations at low or no cost to qualified uninsured and underinsured patients who have a demonstrated financial need |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Business administration of patient pharmaceutical reimbursement programs; business administration of a patient support program for facilitating access to, distribution of, and reimbursement for pharmaceutical products |
| Goods and Services | Informational counseling for patients, namely, providing information and assistance with respect to obtaining prescription medications for medical purposes |
| NOT AVAILABLE | "SUPPORT SERVICES" AND "MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG" |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 20, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | Sunday, December 31, 2023 |
| First Use In Commerce Date | Sunday, December 31, 2023 |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 20, 2022 |
| Primary Code | 036 |
| First Use Anywhere Date | Sunday, December 31, 2023 |
| First Use In Commerce Date | Sunday, December 31, 2023 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 20, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | Sunday, December 31, 2023 |
| First Use In Commerce Date | Sunday, December 31, 2023 |
| Party Name | ImmunoGen, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
| Party Name | ImmunoGen, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
| Party Name | ImmunoGen, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
| Event Date | Event Description |
| Wednesday, December 21, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, December 1, 2022 | NEW APPLICATION ENTERED |
| Tuesday, December 20, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, April 26, 2023 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Sunday, May 21, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, May 23, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 23, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, May 23, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 30, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, June 30, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, June 30, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, June 30, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Friday, June 30, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 30, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 30, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 3, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 19, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 8, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 8, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 3, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, March 8, 2024 | USE AMENDMENT FILED |
| Friday, March 8, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, March 8, 2024 | SOU EXTENSION 1 GRANTED |
| Friday, March 8, 2024 | SOU EXTENSION 1 FILED |
| Monday, April 1, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, May 13, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Monday, May 13, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, March 8, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Saturday, March 9, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, April 1, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, June 18, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 18, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |